Tailoring sickle cell drug doses: a new hope for nigerian patients
Knowledge-focused
Not yet recruiting
This study looks at how genetic differences affect the way Nigerian sickle cell patients respond to hydroxyurea, a common treatment. Researchers will monitor 100 patients to build a computer model that predicts the best dose for each person. The goal is to reduce side effects and…
Sponsor: Ochuko Orherhe • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC